Home » Regions » Global News » Datatrak Q3 Sales Drop by a Third, Loss Narrows

Datatrak Q3 Sales Drop by a Third, Loss Narrows

Tuesday, November 17, 2009

Datatrak International, a technology and services company focused on eClinical solutions, reported third quarter revenues fell 34% to $1.55 million compared with the prior year quarter but its net loss narrowed.

Compared to the prior year third quarter, combined direct cost and selling, general and administrative expenses decreased approximately $1.8 million, or nearly in half.

Datatrak reported a net loss of $(424,000), or $(0.03) per share on a basic and diluted basis, compared with a net loss of $(1.6 million), or $(0.12) per share on a basic and diluted basis, for the same time period of 2008.  Last year’s third quarter net loss included a charge of $835,000 related to its German subsidiary office closing. In addition, the company’s financial results for the prior year third quarter were negatively impacted by legal costs of $234,000 associated with litigation, which was favorably concluded in December 2008 resulting in the forgiveness of $3 million previously owed by Datatrak.

At Sept. 30, backlog was $8.89 million compared with $8.55 million at June 30. The Sept. 30 backlog amount represents the first quarter-over-quarter increase in backlog since the first quarter of 2008.

During the third quarter, the company’s cash balance declined $303,000 to $1.33 million at Sept. 30., compared with $1.63 million as of June 30.

“We believe the increase in backlog is a very good indicator that clinical trial sponsors are ready to move forward with projects which were on hold earlier this year,” said Laurence Birch, chairman of the board of Datatrak.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!